See more : Suntak Technology Co.,Ltd. (002815.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Covetrus, Inc. (CVET) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Covetrus, Inc., a leading company in the Medical – Distribution industry within the Healthcare sector.
- PT Kedoya Adyaraya Tbk (RSGK.JK) Income Statement Analysis – Financial Results
- Atlas Copco AB (ATLCY) Income Statement Analysis – Financial Results
- Pagaya Technologies Ltd. (PGY) Income Statement Analysis – Financial Results
- Lovitt Resources Inc. (LRCFF) Income Statement Analysis – Financial Results
- G Mining Ventures Corp. (GMINF) Income Statement Analysis – Financial Results
Covetrus, Inc. (CVET)
About Covetrus, Inc.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.58B | 4.34B | 3.98B | 3.78B | 3.58B | 3.35B | 2.98B |
| Cost of Revenue | 3.72B | 3.54B | 3.23B | 3.09B | 2.93B | 2.73B | 2.45B |
| Gross Profit | 858.00M | 798.00M | 749.00M | 684.11M | 652.03M | 619.91M | 530.02M |
| Gross Profit Ratio | 18.75% | 18.39% | 18.84% | 18.11% | 18.21% | 18.49% | 17.80% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 867.00M | 808.00M | 538.47M | 516.70M | 488.82M | 417.87M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 881.00M | 867.00M | 808.00M | 538.47M | 516.70M | 488.82M | 417.87M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 881.00M | 867.00M | 808.00M | 538.47M | 516.70M | 488.82M | 417.87M |
| Cost & Expenses | 4.60B | 4.41B | 4.04B | 3.63B | 3.44B | 3.22B | 2.87B |
| Interest Income | 0.00 | 1.00M | 7.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 32.00M | 47.00M | 56.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 200.00M | 190.00M | 176.00M | 64.10M | 59.05M | 55.45M | 50.30M |
| EBITDA | 178.00M | 211.00M | -794.00M | 201.99M | 171.43M | 153.68M | 134.89M |
| EBITDA Ratio | 3.89% | 4.86% | -19.97% | 5.35% | 4.79% | 4.58% | 4.53% |
| Operating Income | -22.00M | -69.00M | -997.00M | 137.10M | 135.32M | 123.83M | 103.81M |
| Operating Income Ratio | -0.48% | -1.59% | -25.08% | 3.63% | 3.78% | 3.69% | 3.49% |
| Total Other Income/Expenses | -32.00M | 45.00M | -32.00M | 6.08M | 3.45M | 2.97M | 4.69M |
| Income Before Tax | -54.00M | -24.00M | -1.03B | 143.18M | 138.77M | 126.79M | 108.50M |
| Income Before Tax Ratio | -1.18% | -0.55% | -25.88% | 3.79% | 3.88% | 3.78% | 3.64% |
| Income Tax Expense | 32.00M | -7.00M | -7.00M | 37.03M | 48.02M | 27.94M | 24.27M |
| Net Income | -86.00M | -19.00M | -1.02B | 100.86M | 64.35M | 70.30M | 60.32M |
| Net Income Ratio | -1.88% | -0.44% | -25.63% | 2.67% | 1.80% | 2.10% | 2.03% |
| EPS | -0.63 | -0.16 | -9.52 | 0.91 | 0.58 | 0.63 | 0.54 |
| EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 | 0.58 | 0.63 | 0.54 |
| Weighted Avg Shares Out | 137.00M | 118.00M | 107.00M | 111.19M | 111.19M | 111.19M | 111.19M |
| Weighted Avg Shares Out (Dil) | 137.00M | 118.00M | 107.00M | 111.19M | 111.19M | 111.19M | 111.19M |
Commonwealth Equity Services LLC Has $143,000 Stock Holdings in Covetrus Inc (NASDAQ:CVET)
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Boosts Stake in Covetrus Inc (NASDAQ:CVET)
Zacks Investment Research Upgrades Covetrus (NASDAQ:CVET) to Buy
APG Asset Management N.V. Acquires Shares of 28,124 Covetrus Inc (NASDAQ:CVET)
COVID-19 Impact and Recovery Analysis- Veterinary Clostridium Vaccine Market 2020-2024 | Dependency on Livestock Products to Boost Growth | Technavio
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2020 Update
Tracking Al Gore's Generation Investment Management Portfolio - Q1 2020 Update
Tracking Allan Mecham's Arlington Value Capital Portfolio - Q1 2020 Update
What Is Michael Burry (Of 'The Big Short') Doing Post COVID-19?
Source: https://incomestatements.info
Category: Stock Reports